180 related articles for article (PubMed ID: 29944447)
21. Generation of Immunodeficient Rats With Rag1 and Il2rg Gene Deletions and Human Tissue Grafting Models.
Ménoret S; Ouisse LH; Tesson L; Delbos F; Garnier D; Remy S; Usal C; Concordet JP; Giovannangeli C; Chenouard V; Brusselle L; Merieau E; Nerrière-Daguin V; Duteille F; Bellier-Waast F; Fraichard A; Nguyen TH; Anegon I
Transplantation; 2018 Aug; 102(8):1271-1278. PubMed ID: 29688994
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models.
Rosato RR; Dávila-González D; Choi DS; Qian W; Chen W; Kozielski AJ; Wong H; Dave B; Chang JC
Breast Cancer Res; 2018 Sep; 20(1):108. PubMed ID: 30185216
[TBL] [Abstract][Full Text] [Related]
23. High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapy.
Nanni P; Nicoletti G; Landuzzi L; Croci S; Murgo A; Palladini A; Antognoli A; Ianzano ML; Stivani V; Grosso V; Maira SM; García-Echeverría C; Scotlandi K; De Giovanni C; Lollini PL
Eur J Cancer; 2010 Feb; 46(3):659-68. PubMed ID: 20031388
[TBL] [Abstract][Full Text] [Related]
24. Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: potential models for studying tumor progression-related changes.
Cutz JC; Guan J; Bayani J; Yoshimoto M; Xue H; Sutcliffe M; English J; Flint J; LeRiche J; Yee J; Squire JA; Gout PW; Lam S; Wang YZ
Clin Cancer Res; 2006 Jul; 12(13):4043-54. PubMed ID: 16818704
[TBL] [Abstract][Full Text] [Related]
25. [The efficacy of TKIs in treatment of human primary small cell lung cancer xenograft model in vivo].
Yu-Hua Z; Liang S; Bin L; Guo-Qiang LI
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2016 Jun; 32(6):525-528. PubMed ID: 29926620
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous xenogeneic GvHD in Wilms' tumor Patient-Derived xenograft models and potential solutions.
Monzavi SM; Muhammadnejad A; Behfar M; Khorsand AA; Muhammadnejad S; Kajbafzadeh AM
Animal Model Exp Med; 2022 Dec; 5(4):389-396. PubMed ID: 35726155
[TBL] [Abstract][Full Text] [Related]
27. A patient-derived xenograft mouse model generated from primary cultured cells recapitulates patient tumors phenotypically and genetically.
Seol HS; Suh YA; Ryu YJ; Kim HJ; Chun SM; Na DC; Fukamachi H; Jeong SY; Choi EK; Jang SJ
J Cancer Res Clin Oncol; 2013 Sep; 139(9):1471-80. PubMed ID: 23817694
[TBL] [Abstract][Full Text] [Related]
28. Differences between immunodeficient mice generated by classical gene targeting and CRISPR/Cas9-mediated gene knockout.
Lee JH; Park JH; Nam TW; Seo SM; Kim JY; Lee HK; Han JH; Park SY; Choi YK; Lee HW
Transgenic Res; 2018 Jun; 27(3):241-251. PubMed ID: 29594927
[TBL] [Abstract][Full Text] [Related]
29. Humanized NOD-SCID IL2rg–/– mice as a preclinical model for cancer research and its potential use for individualized cancer therapies.
Zhou Q; Facciponte J; Jin M; Shen Q; Lin Q
Cancer Lett; 2014 Mar; 344(1):13-19. PubMed ID: 24513265
[TBL] [Abstract][Full Text] [Related]
30. CRISPR-Mediated Knockout of Cybb in NSG Mice Establishes a Model of Chronic Granulomatous Disease for Human Stem-Cell Gene Therapy Transplants.
Sweeney CL; Choi U; Liu C; Koontz S; Ha SK; Malech HL
Hum Gene Ther; 2017 Jul; 28(7):565-575. PubMed ID: 28264583
[TBL] [Abstract][Full Text] [Related]
31. Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies.
Jäger W; Xue H; Hayashi T; Janssen C; Awrey S; Wyatt AW; Anderson S; Moskalev I; Haegert A; Alshalalfa M; Erho N; Davicioni E; Fazli L; Li E; Collins C; Wang Y; Black PC
Oncotarget; 2015 Aug; 6(25):21522-32. PubMed ID: 26041878
[TBL] [Abstract][Full Text] [Related]
32. Breast Cancer Xenograft Murine Models.
Fernando W; Coyle KM; Marcato P
Methods Mol Biol; 2022; 2508():31-44. PubMed ID: 35737231
[TBL] [Abstract][Full Text] [Related]
33. Method for Generating a Patient-Derived Xenograft Model of CLL.
Chen SS
Methods Mol Biol; 2019; 1881():165-171. PubMed ID: 30350205
[TBL] [Abstract][Full Text] [Related]
34. Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models.
Hynds RE; Huebner A; Pearce DR; Hill MS; Akarca AU; Moore DA; Ward S; Gowers KHC; Karasaki T; Al Bakir M; Wilson GA; Pich O; Martínez-Ruiz C; Hossain ASMM; Pearce SP; Sivakumar M; Ben Aissa A; Grönroos E; Chandrasekharan D; Kolluri KK; Towns R; Wang K; Cook DE; Bosshard-Carter L; Naceur-Lombardelli C; Rowan AJ; Veeriah S; Litchfield K; Crosbie PAJ; Dive C; Quezada SA; Janes SM; Jamal-Hanjani M; Marafioti T; ; McGranahan N; Swanton C
Nat Commun; 2024 May; 15(1):4653. PubMed ID: 38821942
[TBL] [Abstract][Full Text] [Related]
35. Antitumor effects of minodronate, a third-generation nitrogen-containing bisphosphonate, in synergy with γδT cells in human glioblastoma in vitro and in vivo.
Nakazawa T; Nakamura M; Matsuda R; Nishimura F; Park YS; Motoyama Y; Hironaka Y; Nakagawa I; Yokota H; Yamada S; Tamura K; Takeshima Y; Omoto K; Tanaka Y; Ouji Y; Yoshikawa M; Tsujimura T; Nakase H
J Neurooncol; 2016 Sep; 129(2):231-41. PubMed ID: 27393349
[TBL] [Abstract][Full Text] [Related]
36. [Establishment and its biological characteristics of patient-derived lung cancer xenograft models].
Zhuo Y; Wu Y; Guo A; Chen S; Su J
Zhongguo Fei Ai Za Zhi; 2010 Jun; 13(6):568-74. PubMed ID: 20681441
[TBL] [Abstract][Full Text] [Related]
37. Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors.
Bondarenko G; Ugolkov A; Rohan S; Kulesza P; Dubrovskyi O; Gursel D; Mathews J; O'Halloran TV; Wei JJ; Mazar AP
Neoplasia; 2015 Sep; 17(9):735-741. PubMed ID: 26476081
[TBL] [Abstract][Full Text] [Related]
38. Patient-derived xenografts of non-small-cell lung cancer: a pre-clinical model to evaluate adjuvant chemotherapy?
Merk J; Rolff J; Becker M; Leschber G; Fichtner I
Eur J Cardiothorac Surg; 2009 Sep; 36(3):454-9. PubMed ID: 19502076
[TBL] [Abstract][Full Text] [Related]
39. Generation of stable PDX derived cell lines using conditional reprogramming.
Borodovsky A; McQuiston TJ; Stetson D; Ahmed A; Whitston D; Zhang J; Grondine M; Lawson D; Challberg SS; Zinda M; Pollok BA; Dougherty BA; D'Cruz CM
Mol Cancer; 2017 Dec; 16(1):177. PubMed ID: 29212548
[TBL] [Abstract][Full Text] [Related]
40. A germline-competent embryonic stem cell line from NOD.Cg-Prkdc ( scid ) Il2rg ( tm1Wjl )/SzJ (NSG) mice.
Landel CP; Dunlap J; Patton JB; Manser T
Transgenic Res; 2013 Feb; 22(1):179-85. PubMed ID: 22767020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
